60 Degrees Pharmaceuticals, Inc.
SXTP· Nasdaq
Released Nov 20, 2023, during market hours
10-Q filed Nov 20, 2023, 51 days after period end · 0001213900-23-088610
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2023 | Q3 2022 |
|---|---|---|
| Revenue | $51.19K | $168.19K |
| Net Income | $4.18M | -$1.45M |
| EPS Diluted | $9.13 | -$0.61 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
60 Degrees Pharmaceuticals, Inc. · CIK 1946563 · Engraved from SEC EDGAR
ended Sep 30, 2023 · filed Nov 20, 2023 · 51 d after period end
7.4% from the close of Nov 16, 2023 to the close of Nov 20, 2023, the first after the release.